

![]() |
A comparison of dequalinium chloride vaginal tablets (Fluomizin®) and clindamycin vaginal cream in the treatment of bacterial vaginosis: a single-blind, randomized clinical trial of efficacy and safety |
|
Authors | ||
Published in | Gynecologic and obstetric investigation. 2012, vol. 73, no. 1, p. 8-15 | |
Abstract | To investigate if vaginal application of dequalinium chloride (DQC, Fluomizin®) is as effective as vaginal clindamycin (CLM) in the treatment of bacterial vaginosis (BV). | |
Keywords | Adolescent — Adult — Candidiasis, Vulvovaginal/etiology — Clindamycin/administration & dosage/adverse effects — Dequalinium/administration & dosage/adverse effects — Female — Follow-Up Studies — Humans — Middle Aged — Single-Blind Method — Treatment Outcome — Vaginal Creams, Foams, and Jellies/administration & dosage — Vaginosis, Bacterial/complications/drug therapy — Young Adult | |
Identifiers | DOI: 10.1159/000332398 PMID: 22205034 | |
Full text | ||
Structures | ||
Research group | Martinez De Tejada Begona (272) | |
Citation (ISO format) | WEISSENBACHER, Ernst Rainer et al. A comparison of dequalinium chloride vaginal tablets (Fluomizin®) and clindamycin vaginal cream in the treatment of bacterial vaginosis: a single-blind, randomized clinical trial of efficacy and safety. In: Gynecologic and obstetric investigation, 2012, vol. 73, n° 1, p. 8-15. doi: 10.1159/000332398 https://archive-ouverte.unige.ch/unige:31855 |